CLEARLAX 100 % — DIN 02324989
POLYETHYLENE GLYCOL 3350 : 100 % · PERRIGO INTERNATIONAL · POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is CLEARLAX?
CLEARLAX 100 % contains POLYETHYLENE GLYCOL 3350 : 100 %. It is listed in the Health Canada Drug Product Database under DIN 02324989, held by PERRIGO INTERNATIONAL, supplied as POWDER FOR SOLUTION for ORAL administration. Health Canada currently lists it as marketed, status dated 28-Jun-2011. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Macrogol cost around the world?
Macrogol is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Bahrain publishes a retail (max); France publishes a reimbursement; Iceland publishes a max wholesale. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| France | reimbursement | 12 | 12 | EUR███.██ |
| Iceland | max wholesale | 2 | 3 | ISK███.██ |
| Bahrain | retail (max) | 1 | 1 | BHD███.██ |
| Saudi Arabia | public | 1 | 1 | SAR███.██ |
17 pack listings across 16 brand entries and 4 price bases, refreshed 09 Sep 2026. Ranges span every Macrogol pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Macrogol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
15 holders have a Canadian DIN containing Macrogol, across 22 DINs, of which 12 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PHARMASCIENCE INC | 4 | 2 | CLARILAX, LAX-A-DAY PHARMA, LAX-RELIEF, LAXATIVE | Sourceable in Canada |
| PERRIGO INTERNATIONAL | 3 | 1 | CLEARLAX, LAXACLEAR, PURELAX | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 1 | EMOLAX, EMOLAX 3350 | Sourceable in Canada |
| PENDOPHARM DIVISION OF PHARMASCIENCE INC | 2 | 1 | LAX-A-DAY, LAX-A-DAY MEN | Sourceable in Canada |
| ANGITA PHARMA INC. 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3 | 1 | 1 | PEG 3350 | Sourceable in Canada |
| BAYER INC | 1 | 1 | RESTORALAX | Sourceable in Canada |
| CELLCHEM PHARMACEUTICALS INC. | 1 | 1 | COMFILAX | Sourceable in Canada |
| JUNO OTC INC | 1 | 1 | HYDRALAX | Sourceable in Canada |
| MANTRA PHARMA INC | 1 | 1 | COLAXOR | Sourceable in Canada |
| MEDEXUS PHARMACEUTICALS INC. | 1 | 1 | RELAXA | Sourceable in Canada |
| MEDISCA PHARMACEUTIQUE INC 6090 Henri Bourassa West St-Laurent Quebec Canada H4R 3A6 | 1 | 1 | PEG 3350 | Sourceable in Canada |
| SEAFORD PHARMACEUTICALS INC | 1 | 0 | POLYLAX | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 % |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Macrogol |
|---|---|
| ATC code | A06AD15 |
| AHFS class | 56:12.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02324989 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2324989 |
| Brand name | CLEARLAX |
| Generic / active ingredient | POLYETHYLENE GLYCOL 3350 : 100 % |
| Market authorization holder | PERRIGO INTERNATIONAL |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | A06AD15 |
| ATC anatomical main group | A — Alimentary tract and metabolism |
| ATC therapeutic subgroup | A06AD |
| Current status | MARKETED |
| Status date | 28-Jun-2011 |
| Original market date | 2010-11-05 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
12 of 22 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| COLAXOR | 100 % | POWDER FOR SOLUTION | MANTRA PHARMA INC | MARKETED | 02450070 |
| COMFILAX | 100 % | POWDER FOR SOLUTION | CELLCHEM PHARMACEUTICALS INC. | MARKETED | 02460297 |
| EMOLAX | 100 % | POWDER FOR SOLUTION | JAMP PHARMA CORPORATION | MARKETED | 02374137 |
| HYDRALAX | 17 G | POWDER FOR SOLUTION | JUNO OTC INC | MARKETED | 02473119 |
| LAX-A-DAY | 100 % | POWDER FOR SOLUTION | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | 02317680 |
| LAX-A-DAY PHARMA | 100 % | POWDER FOR SOLUTION | PHARMASCIENCE INC | MARKETED | 02453193 |
| LAXATIVE | 100 % | POWDER FOR SOLUTION | PHARMASCIENCE INC | MARKETED | 02548933 |
| PEG 3350 | Strength | Powder For Solution | MEDISCA PHARMACEUTIQUE INC 6090 Henri Bourassa West St-Laurent Quebec Canada H4R 3A6 | MARKETED | 02358034 |
| PEG 3350 | Strength | Powder For Solution | ANGITA PHARMA INC. 1310 Rue Nobel Boucherville Quebec Canada J4B 5H3 | MARKETED | 02520796 |
| RELAXA | 100 % | POWDER FOR SOLUTION | MEDEXUS PHARMACEUTICALS INC. | MARKETED | 02346672 |
2 · Same class — other molecules in ATC A06AD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Macrogol | CLARILAX · CLEARLAX · COLAXOR · COMFILAX · EMOLAX · EMOLAX 3350 · HYDRALAX · LAX-A-DAY · LAX-A-DAY MEN · LAX-A-DAY PHARMA · LAX-RELIEF · LAXACLEAR · LAXATIVE · PEG 3350 · PEGALAX · POLYETHYLENE GLYCOL 3350 · POLYLAX · PURELAX · RELAXA · RESTORALAX · RIVA-LAX | 22 | 12 | Yes |
| Lactulose | CEPHULAC SYR 667MG/ML · CHRONULAC SYR · CHRONULAC SYR 667MG/ML · COMALOSE R SIROP 10GM/15ML · DUPHALAC · DUPHALAC DRY · GEN-LAC - LIQ 667MG/ML · JAMP-LACTULOSE · LACTULAX SIROP 10GM/15ML · LACTULOSE · LACTULOSE SOLUTION USP · LACTULOSE SOLUTION USP - LIQ 667MG/ML · LACTULOSE SOLUTION, USP 667MG/ML · LACTULOSE SYRUP · M-LACTULOSE · ORB-LACTULOSE · PHARMA-LACTULOSE · PHL-LACTULOSE SOLN 667MG/ML · PMS-LACTULOSE SYR 667MG/ML · PMS-LACTULOSE-PHARMA · PRO-LACTULOSE - 667 · RATIO-LACTULOSE · TEVA-LACTULOSE · WOODWARD'S LAXATIVE SYRUP | 28 | 5 | Yes |
| Macrogol, Combinations | COLYTE · JAMP-ELECTROPEG · JAMP-ELECTROPEG WITH FLAVOUR PACKET · JAMPLYTE · KLEAN-PREP · MOVIPREP · PLENVU | 8 | 3 | Yes |
| Mineral Salts In Combination | CEO-TWO BOWEL EVACUANT SUPPOSITORIES · EAU PURGATIVE RIGA · ELECTROPEG SOLUTION · GOLYTELY GI LAVAGE SOLUTION · KLEAN-PREP · LYTEPREP · OCL SOLUTION · PEGLYTE POWDER · PEGLYTE SOLUTION · PMS-PEGLYTE · PROLAX - PWS · RIGA PURGATIVE LEMON FLAV LIQ | 13 | 1 | Yes |
| Magnesium Sulphate | EPSOM SALT PWS 100% · EPSOM SALTS · SEL D EPSOM | 6 | 0 | Not in Canada |
| Magnesium Sulphate, Combinations | AGOBYL GRANULE · AGOBYL LIQUIDE · FORMULE 1705 - LIQ | 3 | 0 | Not in Canada |
| Sodium Phosphate | EURO-PHOSPHATES SOLUTION · PHOSPHO-SODA BUFFERED SALINE LAXATIVE · PMS-PHOSPHATES SOLUTION | 3 | 0 | Not in Canada |
| Sorbitol | SORBITOL ROUGIER PWS 5GM | 1 | 0 | Not in Canada |
| Sodium Tartrate | LIMONADE RODECA | 1 | 0 | Not in Canada |
| Magnesium Oxide | MAGNESIUM CITRATE ORAL SOLUTION | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC A06A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| A06AB | Bisacodyl · Bisacodyl, Combinations · Cascara · Cascara, Combinations · Castor Oil · Contact Laxatives · Contact Laxatives In Comb W/ Belladonna Alkaloids · Contact Laxatives In Combination · Dantron, Combinations · Phenolphthalein · Phenolphthalein, Combinations · Senna Glycosides · Senna Glycosides, Combinations · Sodium Picosulfate, Combinations | 239 | 25 |
| A06AA | Docusate Sodium · Docusate Sodium, Combinations · Liquid Paraffin · Liquid Paraffin, Combinations | 144 | 22 |
| A06AX | Glycerol · Linaclotide · Lubiprostone · Other Laxatives · Plecanatide · Prucalopride · Tenapanor | 30 | 14 |
| A06AH | Methylnaltrexone Bromide · Naloxegol | 5 | 3 |
| A06AG | Bisacodyl · Combinations · Docusate Sodium, Incl Combinations · Sodium Phosphate | 7 | 1 |
| A06AC | Ispaghula (Psylla Seeds) · Ispaghula, Combinations · Linseed · Methylcellulose · Polycarbophil Calcium · Sterculia · Triticum (Wheat Fibre) | 79 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CLEARLAX called?
The same molecule, Macrogol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Miralax | Latin | Iceland |
| Forlax Junior | Latin | Iceland |
| MOVICOL | Latin | Bahrain |
| Movicol Paediatric Plain | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.